Digital Health Monthly: Scientific Webinar Series
AI, Sensors, and Regulation: What We Learned at ADDS Basel and Why It Matters
Wednesday, November 19 @ 12 PM ET
Upcoming Digital Health Monthly:
Scientific Webinar Series
Accelerating DHT Research and Drug Development with Open-Source Big Data from Population Studies
Tuesday, December 3 @ 12 PM ET
Digital Health Monthly: Scientific Webinar Series
Sensor-based DHTs are shedding an illuminating light on how people function in their real-world environments. Drug developers, researchers, patients, and regulators are realizing the multifaceted value sensor-based DHTs can bring to clinical research.
As their adoption continues to grow, the ActiGraph team is excited to continue ‘Digital Health Monthly’, a monthly series of science-focused webinars to share the latest high-impact developments in clinical research from innovators in the digital health field. Each month, we feature brief data-driven presentations from clinical researchers, data scientists, and biostatisticians on a focused topic with dedicated time for audience Q&A. We believe that together, we can move the digital health technology field forward faster, and we are excited for this opportunity to facilitate important discussions on the latest research with members of the digital health community.
Artificial intelligence, advanced sensors, and evolving regulatory frameworks are shaping the next wave of digital health technology (DHT) adoption in clinical research.
Join us on Nov 19 for a special Digital Health Monthly webinar highlighting key insights from the recent ADDS Basel 2025, the first European edition of our flagship scientific conference. During this webinar, we’ll discuss the latest trends, data, and perspectives driving digital transformation in clinical research, from how AI models are being trained on massive real-world datasets, to how novel sensor-based measures are being validated for regulatory use.
You’ll learn how clinical research teams are:
- Leveraging AI and machine learning to extract meaningful insights from continuous digital data.
- Expanding the use of sensor-derived measures across neurology, oncology, and cardiopulmonary indications.
- Navigating the path toward regulatory maturity for DHT-derived endpoints.
Whether you attended ADDS Basel or are preparing for ADDS Atlanta 2026, this session will help you understand how these emerging trends are shaping the future of evidence generation and regulatory acceptance in digital health.
Don’t miss this opportunity to stay at the forefront of DHT innovation and learn what these developments mean for your research and regulatory strategy.
